170 related articles for article (PubMed ID: 26514453)
1. Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors by Modulating P-Glycoprotein through Dietary Nutraceuticals.
Khan M; Maryam A; Mehmood T; Zhang Y; Ma T
Asian Pac J Cancer Prev; 2015; 16(16):6831-9. PubMed ID: 26514453
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin and Piperine Can Overcome Multidrug Resistance in Cancer Cells to Doxorubicin.
Li H; Krstin S; Wang S; Wink M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498663
[TBL] [Abstract][Full Text] [Related]
3. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
4. Overcoming vincristine resistance in cancer: Computational design and discovery of piperine-inspired P-glycoprotein inhibitors.
Syed SB; Lin SY; Arya H; Fu IH; Yeh TK; Charles MRC; Periyasamy L; Hsieh HP; Coumar MS
Chem Biol Drug Des; 2021 Jan; 97(1):51-66. PubMed ID: 32633857
[TBL] [Abstract][Full Text] [Related]
5. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
6. Overcoming multidrug resistance in human cancer cells by natural compounds.
Nabekura T
Toxins (Basel); 2010 Jun; 2(6):1207-24. PubMed ID: 22069634
[TBL] [Abstract][Full Text] [Related]
7. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells.
Li S; Lei Y; Jia Y; Li N; Wink M; Ma Y
Phytomedicine; 2011 Dec; 19(1):83-7. PubMed ID: 21802927
[TBL] [Abstract][Full Text] [Related]
8. Selective Cytotoxicity of Piperine Over Multidrug Resistance Leukemic Cells.
Quarti J; Torres DNM; Ferreira E; Vidal RS; Casanova F; Chiarini LB; Fialho E; Rumjanek VM
Molecules; 2021 Feb; 26(4):. PubMed ID: 33578817
[TBL] [Abstract][Full Text] [Related]
9. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.
Eid SY; El-Readi MZ; Eldin EE; Fatani SH; Wink M
Phytomedicine; 2013 Dec; 21(1):47-61. PubMed ID: 23999162
[TBL] [Abstract][Full Text] [Related]
10. Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters.
Eid SY; El-Readi MZ; Wink M
Phytomedicine; 2012 Aug; 19(11):977-87. PubMed ID: 22770743
[TBL] [Abstract][Full Text] [Related]
11. Marine Natural Products as Models to Circumvent Multidrug Resistance.
Long S; Sousa E; Kijjoa A; Pinto MM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
[TBL] [Abstract][Full Text] [Related]
12. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression.
Nobili S; Landini I; Mazzei T; Mini E
Med Res Rev; 2012 Nov; 32(6):1220-62. PubMed ID: 21374643
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
14. Combating P-glycoprotein-mediated multidrug resistance using therapeutic nanoparticles.
Zhang Q; Li F
Curr Pharm Des; 2013; 19(37):6655-66. PubMed ID: 23621532
[TBL] [Abstract][Full Text] [Related]
15. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
Liu DL; Li YJ; Yao N; Xu J; Chen ZS; Yiu A; Zhang CX; Ye WC; Zhang DM
Eur J Pharmacol; 2014 Jun; 733():34-44. PubMed ID: 24704556
[TBL] [Abstract][Full Text] [Related]
16. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
[TBL] [Abstract][Full Text] [Related]
17. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.
Syed SB; Arya H; Fu IH; Yeh TK; Periyasamy L; Hsieh HP; Coumar MS
Sci Rep; 2017 Aug; 7(1):7972. PubMed ID: 28801675
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment.
Katiyar SS; Muntimadugu E; Rafeeqi TA; Domb AJ; Khan W
Drug Deliv; 2016 Sep; 23(7):2608-2616. PubMed ID: 26036652
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid.
Junco JJ; Mancha A; Malik G; Wei SJ; Kim DJ; Liang H; Slaga TJ
Mol Cancer Res; 2013 Dec; 11(12):1521-9. PubMed ID: 24072817
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Traditional Chinese Medicine on P-Glycoprotein-Mediated Multidrug Resistance and Approaches for Studying the Herb-P-Glycoprotein Interactions.
Cao Y; Shi Y; Cai Y; Hong Z; Chai Y
Drug Metab Dispos; 2020 Oct; 48(10):972-979. PubMed ID: 32816867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
